Lonza receives Swissmedic approval for Biologics drug product filling line in Stein
New filling line approval supports delivery of integrated, end-to-end solutions across the entire biologics and bioconjugates value chain
New filling line approval supports delivery of integrated, end-to-end solutions across the entire biologics and bioconjugates value chain
Lupin's partnership program is designed to foster collaborations with companies looking to extend their product lifecycles
Panacea Biotec receives acceptance from CMSS for supply of bOPV
Conventional plasmids as a pharmaceutical material are not only suboptimal in safety and function, but exceedingly costly to produce, prohibitively
Liothyronine tablets will be manufactured at Zydus' plant in Ahmedabad SEZ
IMCD engaged with manufacturers, formulators, and brand leaders, offering valuable insights into evolving consumer trends
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
Lonza boosts TheraPEAK line with new Cytokines and AAV Medium for next-gen therapies
States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
Subscribe To Our Newsletter & Stay Updated